Liu Kai-Long, He Jie, Zang Ya-Jing
Kai-long Liu, Department of Neurology, Tangxian people's Hospital, Baoding 072350, Hebei, China.
Jie He, Department of Neurology, Tangxian people's Hospital, Baoding 072350, Hebei, China.
Pak J Med Sci. 2022 May-Jun;38(5):1143-1149. doi: 10.12669/pjms.38.5.5255.
To evaluate the clinical effect of intravascular interventional therapy in the treatment of acute ischemic stroke and its influence on cognitive function, cerebral hemodynamics and inflammatory factors as well as its clinical significance.
Eighty patients with acute ischemic stroke admitted to Tangxian people's Hospital from January 2018 to January 2020 were randomly divided into two groups. Patients in the control group were treated with conventional thrombolytic therapy on the basis of basic treatment, while patients in the experimental group were given intravascular interventional treatment on the basis of conventional treatment. Clinical effect, recovery of cognitive function and activities of daily living, improvement of cerebral hemodynamics indexes, and changes of inflammatory factors before and after treatment were analyzed by combining NIHSS score and symptom improvement before and two months after treatment, respectively.
The effective rate of the experimental group was 82.5% after treatment, and that of the control group was 60%, with a statistically significant difference (P =0.02). Mini-mental State Examination (MMSE) and Barthel scores of the experimental group were significantly improved compared with those of the control group after treatment, with statistically significant differences between the two groups (P=0.00). The mean cerebral vascular blood flow (Qm) of the experimental group increased significantly after treatment compared with that of the control group, while vascular characteristic impedance (ZCV) and peripheral resistance (Rv) decreased significantly in the experimental, with a statistically significant difference (ZCV, P=0.01; Rv, P=0.05); After treatment, TNF- A, CRP, IL-6 and other indicators in the experimental group were significantly lower than those in the control group, with statistically significant differences (P=0.00).
Intravascular interventional therapy is an effective treatment regimen for acute ischemic stroke boasting a variety of advantages over conventional thrombolysis, such as significant symptom improvement, high efficacy, favourable recovery of cognitive function and activities of daily living, improvement of cerebral hsemodynamic indicators, and significant reduction of inflammatory cytokine levels.
评估血管内介入治疗对急性缺血性脑卒中的临床疗效及其对认知功能、脑血流动力学和炎症因子的影响及其临床意义。
选取2018年1月至2020年1月在唐县人民医院收治的80例急性缺血性脑卒中患者,随机分为两组。对照组患者在基础治疗的基础上采用传统溶栓治疗,而实验组患者在常规治疗的基础上给予血管内介入治疗。分别结合美国国立卫生研究院卒中量表(NIHSS)评分以及治疗前和治疗后两个月的症状改善情况,分析临床疗效、认知功能和日常生活活动能力的恢复情况、脑血流动力学指标的改善情况以及治疗前后炎症因子的变化。
治疗后实验组有效率为82.5% ,对照组为60% ,差异有统计学意义(P =0.02)。治疗后实验组简易精神状态检查表(MMSE)和巴氏指数评分较对照组显著提高,两组差异有统计学意义(P=0.00)。治疗后实验组平均脑血管血流量(Qm)较对照组显著增加,而实验组血管特性阻抗(ZCV)和外周阻力(Rv)显著降低,差异有统计学意义(ZCV,P=0.01;Rv,P=0.05);治疗后实验组肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)、白细胞介素-6(IL-6)等指标显著低于对照组,差异有统计学意义(P=0.00)。
血管内介入治疗是急性缺血性脑卒中的一种有效治疗方案,与传统溶栓相比具有多种优势,如症状改善显著、疗效高、认知功能和日常生活活动能力恢复良好、脑血流动力学指标改善以及炎症细胞因子水平显著降低。